Eisai GmbH

Biocompatibles International plc - Statement re Positive Data in Combination Therapy Trial.
PR Newswire UK Disclose; 11/3/2009; 1948 words; ...partners include AngioDynamics Inc., Terumo Corporation and Eisai Co. Ltd. We have a clinical collaboration agreement with Bayer...cosmetic Dermatology Bead partnered with Merz Pharmaceuticals GmbH. We also have a PC Licensing agreement with Medtronic Inc...

Biocompatibles International plc - Statement re regulatory application in China.
PR Newswire UK Disclose; 8/7/2009; 1015 words; ...partners include AngioDynamics Inc., Terumo Corporation and Eisai Co. Ltd. Our R&D Facilities are engaged in licensing...Pharmaceuticals Inc., Medtronic Inc. and Merz Pharmaceuticals GmbH. This news release contains forward-looking statements that...

Novel Chemotherapy Agent Bendamustine Significantly More Effective First-Line Therapy Than Chlorambucil in CLL.(Clinical report)
PR Newswire Europe; 8/4/2009; 1768 words; ...leukaemia (CLL). RIBOMUSTIN is licensed from Astellas Deutschland GmbH. In the United States, bendamustine (TREANDA(R)) is marketed...develop and market bendamustine HCL in Japan (sublicensed to Eisai Co Ltd) and selected Asian countries. Bendamustine is currently...

Biocompatibles International plc - Statement re Option to License Exercised in Japan.
PR Newswire UK Disclose; 7/28/2009; 991 words; ...pounds sterling]3m initial milestone as Eisai exercises its option to license Drug...LSE:BII) is pleased to announce that Eisai Co Ltd (TSE4523.JP) has exercised its...substantial, additional consideration based on Eisai's achievement of various commercial and...

Research and Markets Adds Report: Therapeutic Monoclonal Antibodies Markets.
Health & Beauty Close-Up; 6/30/2009; 798 words; ...Cambridge Antibody Technology Group - Crucell NV - Cytogen - Dyax - Eisai Co., Ltd. - Elan Corp. - Eli Lilly - Elusys Therapeutics - Enzon Pharmaceuticals - Genentech - Genmab A/S - Genovac GmbH - Genzyme Corp. - GlaxoSmithKline plc - ImClone Systems - ImmunoGen...